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Purpose: Multifocal visual evoked potential (mfVEP) is a newly introduced method used for objective visual field 
assessment. Several analysis protocols have been tested to identify early visual field losses in glaucoma patients 
using the mfVEP technique, some were successful in detection of field defects, which were comparable to the 
standard automated perimetry (SAP) visual field assessment, and others were not very informative and needed 
more adjustment and research work. In this study we implemented a novel analysis approach and evaluated its 
validity and whether it could be used effectively for early detection of visual field defects in glaucoma. 
Methods: Three groups were tested in this study; normal controls (38 eyes), glaucoma patients (36 eyes) and glauco-
ma suspect patients (38 eyes). All subjects had a two standard Humphrey field analyzer (HFA) test 24-2 and a sin-
gle mfVEP test undertaken in one session. Analysis of the mfVEP results was done using the new analysis protocol; 
the hemifield sector analysis (HSA) protocol. Analysis of the HFA was done using the standard grading system.
Results: Analysis of mfVEP results showed that there was a statistically significant difference between the three 
groups in the mean signal to noise ratio (ANOVA test, p < 0.001 with a 95% confidence interval). The differ-
ence between superior and inferior hemispheres in all subjects were statistically significant in the glaucoma 
patient group in all 11 sectors (t-test, p < 0.001), partially significant in 5 / 11 (t-test, p < 0.01), and no statistical 
difference in most sectors of the normal group (1 / 11 sectors was significant, t-test, p < 0.9). Sensitivity and 
specificity of the HSA protocol in detecting glaucoma was 97% and 86%, respectively, and for glaucoma sus-
pect patients the values were 89% and 79%, respectively.
Conclusions: The new HSA protocol used in the mfVEP testing can be applied to detect glaucomatous visual 
field defects in both glaucoma and glaucoma suspect patients. Using this protocol can provide information 
about focal visual field differences across the horizontal midline, which can be utilized to differentiate between 
glaucoma and normal subjects. Sensitivity and specificity of the mfVEP test showed very promising results 
and correlated with other anatomical changes in glaucoma field loss.
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Early diagnosis and effective monitoring of glaucoma 
are considered the major concerns and objectives in almost 
all of the research studies conducted in the field of glauco-
ma management. Visual field assessment is still the main 
monitoring tool that ref lects progressive glaucomatous 
functional loss. It has been reported [1,2] that at least 25% 
to 50% of the retinal ganglion cells must be lost prior to 
the development of a field abnormality detectable with 
modern automated visual field testing. The introduction of 
standard automated perimetry (SAP) has improved accu-
racy and reduced variability errors compared to earlier ki-
netic perimeters. However, SAP protocols do not provide a 
fully accurate visual field assessment profile due to many 
factors affecting the final results, including and not limited 
to subjectivity. Almost all perimetry software and testing 
strategies have attempted to overcome some or all of these 
problems with various degrees of accuracy and success. 
Despite its disadvantages, which can be clearly seen with 
long test duration and variability, the Humphrey field ana-
lyzer (HFA) is considered the gold standard method for vi-
sual field assessment in clinical practice and glaucoma re-
lated clinical trials [1,3]. However, the full-threshold visual 
field test is currently regarded as a quasi-standard in day-
to-day perimetry testing [4]. To more accurately detect 
glaucomatous visual field defects and their progression, 
test strategies that provide repeatable threshold estimates 
in damaged locations are necessary [5]. Multifocal visual 
evoked potential (mfVEP) is a newly introduced method for 
objective assessment of visual field impairment. Over the past 
decades, the method has been used to detect glaucomatous vi-
sual field defects with high sensitivity and specificity and to 
monitor and detect progression of glaucoma through good re-
peatability figures [6-8]. It was reported [9] that mfVEP can 
detect damage missed by HFA. Furthermore, abnormal 
mfVEPs have been reported in patients with normal HFAs.
The ability of the test to provide credible information 
about the visual field is essentially controlled by its ability 
to show good repeatability scores. Decisions related to 
management are mainly dependent on the accurate sensi-
tivity and specificity figures of the test and its ability to 
show consistent results over time. mfVEP has been shown 
in many studies to provide a good level of repeatability 
among normal subjects and glaucoma patients in short and 
long reassessment intervals [10-15]. For example, Baseler 
et al. [16] evaluated mf VEP responses in controls and 
glaucoma patients on two separate occasions and found no 
significant differences in responses across the field. In two 
separate studies, Goldberg et al. [17] and Klistorner et al. 
[18] measured the coefficient of variation between two suc-
cessive mfVEP tests in two groups and reported a low val-
ue (16%) confirming a good level of repeatability of the 
mfVEP test. Other studies have compared the repeatability 
of mfVEP tests compared to standard HFA results. For ex-
ample, Chen et al. [15] reported better repeatability of the 
mfVEP test, where signal amplitudes were more reliable 
than SAP thresholds. From previous studies [19,20], it is 
evident that mfVEP repeatability is at least equal to, or 
some studies, better than standard SAP results; thus, mak-
ing the test useful for diagnosis of early-stage glaucoma 
and as a follow-up tool to monitor progression of the disease.
Materials and Methods
This study was conducted at the ophthalmology outpa-
tient clinic, Hamad Medical Corporation, Doha, Qatar. 
Study subjects were selected from patients attending the 
ophthalmology outpatient clinics during the recruitment 
period, which was between March and June 2012. All 
study subjects were screened by a full eye examination be-
fore enrollment by a glaucoma specialist; including intra-
ocular pressure, Gonioscopy, visual acuity using the Snel-
len chart, slit lamp assessment of the anterior segment, and 
retinal examination including the optic nerve head (optic 
disc). Subjects were categorized into three groups; glauco-
ma, glaucoma suspect, and normal controls.
Selection criteria for glaucoma and glaucoma suspect 
patients followed the guidelines of the American Academy 
of Ophthalmology Preferred Practice Pattern (AAO-PPP) 
in the precise definition of glaucoma and glaucoma suspect 
patients [21]. The glaucoma patient group included any pa-
tient with previously diagnosed and well-documented fea-
tures of any type of glaucoma as defined by the AAO-PPP 
guidelines, including: 1) Patients with evidence of optic 
nerve damage demonstrated by neuroretinal thinning as-
sociated with cupping or other signs of glaucomatous optic 
disc changes. 2) Reliable and reproducible glaucomatous 
visual field abnormality consistent with ganglion cell dam-
age, showing a significant difference between the two 
hemispheres, in the absence of any other causes or expla-
nations. A glaucoma-suspect patient is defined as an indi-
vidual with clinical findings and/or constellation of risk 
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factors that indicate an increased likelihood of developing 
glaucoma, including any patient with a well-documented 
risk factor of glaucoma without any anatomical or func-
tional damage to the optic nerve as defined by the AAO-
PPP guidelines. The glaucoma risk factors considered in-
clude: 1) Suspicious appearance of the optic disc such as 
enlarged cup-disc ratio, asymmetric cup-disc ratio, notching 
or narrowing of the neuroretinal rim, disc hemorrhages, or 
nerve fiber layer defect. 2) Suspicious visual field for glauco-
matous damage in the absence of clinical signs of other optic 
neuropathy, such as arcuate bundle defect, nasal step, para-
central scotoma, altitudinal defect, or larger mean pattern 
standard deviation. 3) Consistently elevated intraocular pres-
sure associated with normal appearance of the optic disc 
and retinal nerve fiber layer and with normal visual field test 
results. Normal subjects were recruited after excluding any 
existing ocular pathology. Both genders were equally invited 
to participate in this study. There was no language restric-
tions applied when subjects were recruited.
Subjects suffering from visual field defects due to any 
pathology other than glaucoma, significant retinal disease 
with or without macular involvement, established neuro-
logical deficits affecting the visual cortex or visual path-
ways, or subjects with amblyopia were excluded from joining 
this study. Subjects under the age of 16 were not recruited for 
this study because of the high level of variability and poor 
reliability of the SAP test for patients under the age of 16 
[22-24]. Vulnerable subjects suffering from mental or physi-
cal disability, and/or severely debilitated patients needing 
continuous and special care were excluded from this study.
Multifocal visual evoked potential test
1) Multifocal visual evoked potential test parameters
To measure the amplitude of these responses, the root 
mean square (RMS) was calculated across the interval from 
0 to 500 msec. RMS is commonly used because it requires 
only the specification of a time interval rather than the iden-
tification of a particular aspect of the response waveform. 
We used a signal window between 0 to 200 msec and a 
noise window between 300 to 500 msec (Fig. 1). In addition 
to measuring the RMS of each of the 58 responses for each 
eye, an signal to noise ratio (SNR) measure was obtained as 
previously described. In order to obtain the SNR of any seg-
ment, a signal window (0 to 200 msec) and a “noise-only” 
window (300 to 500 msec) are specified. The SNR of a giv-
en response is obtained by dividing the RMS of the signal 
window by the average of the 58 segments × 4 channels = 
232 RMS values of the noise-only window. 
A response without any signal present would have, on av-
erage, an SNR equal to 1.0. The records from the four chan-
nels are all oriented in polarity so that if a response was 
present, it should have a prominent negative component fol-
lowed by a prominent positive component. There is little or 
no response present for the record with an SNR around 1.0, 
and the signal becomes more salient as the SNR increases.
2) Stimulus
According to the guidelines of the International Society 
of Clinical Electrophysiology of Vision [25] there is a stan-
dard requirement for multifocal stimuli. We fulfilled the 
required standards using a cathode ray tube (CRT) defini-
tion frame frequency of 75 Hz, which has been used wide-
ly. For CRT displays, the luminance of the stimulus ele-
ments in the light state was least 100 cd/m2. The luminance 
of the display in the dark state was low enough to achieve 
a contrast (Michelson of ≥90% using an m-sequence) and 
was used to control the temporal sequence of change be-
tween the light and dark stages of each stimulus hexagon. 
Currently there is no standard display for the mfVEP tech-
nique. Recordings have been obtained using the dartboard 
pattern which is a standard option (Dart Board 58 with 
Fig. 1. The typical multifocal visual evoked potential signal is 
divided into two parts (windows) according to implicit time. The 
signal window between 0 to 200 msec and the noise window be-
tween 300 to 500 msec. Signal to noise ratio is calculated based 
on this division of the waveform.
0
Signal window
0-200
200100 300 400 500 (msec)
Noise window
300-500
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Average RMS noise from 58 sectorsSNR =
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Pattern Segments) of the Roland Consult GmbH software, 
RETIscan (Roland Consult, Brandenburg, Germany). A 
modified version of this pattern was recently introduced as 
part of the hemifield sector analysis (HSA) protocol (Fig. 
2). The modification is based upon the novel idea of the 
present study to record the SNR values of each segment 
(Fig. 3A), then calculating the average of individual sectors 
that contain a fixed number of segments (Fig. 3B). Each 
sector SNR value in one hemisphere was compared to its 
corresponding sector in the other hemisphere to calculate 
the difference between the two fellow sectors. Similar av-
eraging and calculations were done in a hemi-ring group 
of segments arranged circumferentially around the central 
part as shown in Fig. 3C and 3D. SNR values from each 
two fellow hemi-rings were compared to see if there was 
any statistical difference between each couple of sectors/
hemi-rings in the three subject groups. The dartboard pat-
tern was presented on a monitor viewed at a distance of 30 
cm, and the diameter of the display subtended 44.51 cm. 
There were 58 sectors in this display and each sector con-
tained 16 checks, 8 black and 8 white. The dartboard pat-
tern covered a central 25° on each side of the fixation point 
with a nasal extension wing up to 42°. The segments and 
checks were scaled to be approximately equal in effective-
ness, according to cortical magnification factors presented 
by Baseler et al. [16].
Each participant had undertaken two HFA 24-2 Swedish 
Interactive Threshold Algorithms (SITA) standard tests 
with one hour apart during their enrollment period. Pa-
tients were instructed in a clear and informative language 
on how to take the HFA tests effectively without errors. 
The second HFA test was the study test and all of its data 
were recorded and analyzed if subjects were within the re-
liability criteria of 33% false positive and false negative 
rates and 20% fixation losses. One or both tests could have 
been repeated on an individual basis if the results were not 
accurate or if they contained a high level of noise. When 
finished, each participant got both eyes dilated using a top-
ical mydriatic (dilating drops). When both eyes were fully 
dilated the patient was prepared and connected to take the 
second test, which was the mfVEP. During the mfVEP 
test, the subject was asked to focus on a screen that project-
ed flickering hexagon patterns on the patient’s eye. Total 
time for the 2-run test was 8 to 16 minutes per eye, during 
which; the examiner was monitoring the patient’s eye to ob-
serve any unwanted eye movements, which could affect the 
results. However, those subjects who failed to take any of 
the tests effectively had to retake them at a later time. A test 
was counted as “not valid” if it contained too much noise or 
errors. Total duration of attendance for each subject ranged 
between 45 to 90 minutes, dependent on individual test-tak-
ing variations among the subjects. No follow-up visits were 
required, and all recordings were taken in a single session.
Fig. 2. The five allocated hemi-rings and their corresponding fellows in both hemispheres (A). The allocated six sectors and their corre-
sponding fellows in both hemispheres (B). SR = superior hemi-ring; IR = inferior hemi-ring; SS = superior sector; IS = inferior sector.
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Recording system
The RETIscan system manufactured by Roland Consult, 
Germany was the system used for performing all mfVEP 
tests in this study. All participants were optimally refract-
ed for near vision. An appropriate trial lens was placed in 
front of the patient’s eye during the test for optimal visual 
acuity in the near distance. Patients were seated 30 cm 
from the screen and instructed to stay focused on the cen-
tral target and not to move their eyes during the test. 
Hemifield sector/hemi-ring analysis protocol
The concept of the analysis protocol, as described earli-
er, is to compare and divide the mfVEP field into similar 
(equal) sectors and hemi-rings across the horizontal merid-
ian, where a sector at the superior hemisphere is compared 
to its corresponding fellow sector in the inferior hemi-
sphere. The allocated sectors and hemi-rings, shown in Fig. 
2, comprise a fixed number of segments. After the SNR 
value from each segment is recorded, an average is taken 
Fig. 3. The 58 segments of the right visual field. The field is divided into two identical hemifields across the horizontal meridian; each 
segment has a similar correspondent in the opposite hemifield. (A) Signal to noise ratio (SNR) value is calculated for each segment. The 
average SNR of wedge sectors (B) and semicircular sectors; peripheral and central sectors (C,D) are calculated to compare their values to 
fellow corresponding sectors on the opposite hemifield.
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from all the segments allocated to any given sector, to give 
a sector average SNR value. This sector SNR value is the 
one that will be compared to its corresponding sector 
across the horizontal meridian and not the individual seg-
ments. Certain measurable parameters were recorded and 
calculated using this HSA protocol in order to compare the 
three groups. The SNR value in each sector/hemi-ring was 
compared to its corresponding sector in the opposite hemi-
sphere and the difference was calculated to check for any 
significant change between corresponding sectors/hemi- 
rings. The same SNR values and difference between sectors/
hemi-rings were also compared to identical ones in the three 
groups to check for any significant change between groups.
Humphrey field analyzer Swedish Interactive Threshold 
Algorithms standard 24-2
All study subjects had one or two HFA tests; the first to 
familiarize the test taker with the test process and to mini-
mize reliability errors. If the subject had already taken the 
test before and was familiar with the procedure then this 
first test was waived. The second test was the study test 
and all of its data were recorded and analyzed. All subjects 
had the SITA standard 24-2 using HFA automated perime-
try as the gold standard visual field test. Measurable pa-
rameters recorded in the HFA test included mean deviation 
(MD), pattern standard deviation (PSD), and glaucoma 
hemifield test (GHT) grading. Most of these parameters 
were used in the HFA grading scale of visual field severity.
Statistical analysis
All data obtained from the three study groups were ana-
lyzed using the new HSA protocol. mfVEP data from the 
three study groups were compared to SAP test results to 
check for significant differences or agreement. The final out-
come of comparison and evaluation of the data confirmed or 
rejected the validity of the new analysis protocol in detecting 
visual field defects. All SNR values from individual sectors/
hemi-rings, in all groups, were tested for normality using the 
Kolmogorov-Smirnov and shapiro-wilk tests. Each sector 
SNR value in one hemisphere was compared to its corre-
sponding sector in the other hemisphere to calculate the dif-
ference between two corresponding sectors. Similar averag-
ing and calculations were done in the hemi-ring group of 
segments arranged circumferentially around the central part 
as shown in Fig. 3C and 3D. SNR values from each of the two 
corresponding hemi-rings were compared to see if there was 
any statistical difference between each couple of sectors/hemi-
rings in the three subject groups. The paired t-test was performed 
to check for statistical significance for all sectors and hemi-rings. 
The one way ANOVA test was performed to check for statistical 
significance between groups. Agreement between HFA and 
SNR was perfomed using Kappa statistics. Receiver operating 
characteristic (ROC) cutoff values for glaucoma and normal 
groups were used to perform Kappa statistical agreement tests. 
An SNR value of 1.99 at a sensitivity level of 97% and specificity 
of 86%, as detected by the ROC curve, was used as a cutoff value; 
where any response above this value was considered as a normal 
response. Kappa statistical analysis showed good agreement be-
tween HFA and SNR.
Results
A total of 60 subjects (112 eyes) were recruited and enrolled 
in this study (Table 1). Participants included 20 (38 eyes) nor-
mal subjects, 20 (38 eyes) glaucoma suspects, and 20 (36 eyes) 
glaucoma patients. All subjects had two HFA-SITA standard 
24-2 visual tests and a single mfVEP test. All study subjects 
were able to finish two cycles of the mfVEP test successfully 
with no significant complaints or side effects. The test dura-
tion for the SITA standard HFA test ranged between 4 to 11 
minutes per eye, while the duration of a single (two cycles) 
mfVEP test ranged between 8 to 16 minutes per eye exclud-
ing preparation time. The mfVEP preparation time was simi-
lar in all subjects and ranged between 13 to 20 minutes per 
patient. Table 1 shows the age distribution of all subjects in 
the three study groups. There was no significant difference in 
age distribution detected among the three study groups (p = 
0.673). The mean age for all study subjects was 40.65 years, 
with no significant preference between genders in any study 
group. There was no substantial variability in age or gender 
among the study groups. Subject age ranged between 19 to 72 
in all groups, as we tried to cover a wide range of age matched 
responses in the three groups.
Multifocal visual evoked potential test results
1)  Multifocal visual evoked potential sensitivity and speci-
ficity figures
Fig. 4 shows the ROC analysis for the glaucoma suspect 
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group. The area under the curve (0.892) displayed high sensi-
tivity and specificity for detection of glaucoma suspect pa-
tients (89% and 79%, respectively). We calculated 89% sensi-
tivity using an SNR value of 2.38 as the cut-off for glaucoma 
suspect patients. Fig. 5 shows the ROC analysis for the glau-
coma group. The area under the curve (0.989) displayed high 
sensitivity and specificity for detection of glaucoma (97% and 
86%, respectively). We calculated 97% sensitivity using an 
SNR value of 1.99 as the cut-off for glaucoma.
2) Intragroup analysis
Normal group
Twenty normal subjects (38 eyes) were recruited and test-
ed. None of the subjects showed a history or clinical findings 
of ocular diseases that could interfere with the field of vision 
as listed in the selection criteria during assessment and ex-
amination. Table 2 shows the results in detail; there was only 
one sector (1 / 6) found significant when compared to its 
corresponding one on the opposite hemifield, and no hemi-
rings (0 / 5) were found to be significant.
Fig. 4. Receiver operating characteristic analysis for the glauco-
ma suspect group by multifocal visual evoked potential testing in 
the glaucoma suspect group.
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Fig. 5. Receiver operating characteristic analysis for the glau-
coma group by multifocal visual evoked potential testing in the 
glaucoma suspect group.
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Table 1. Analysis of age in all study groups
Groups Gender
Number Age
p-value*
Subjects (%) Eyes (%) Mean SD Age range
All subjects Male 31 (51) 58 (52) 39.51 12.521 19-68 0.673
Female 29 (49) 54 (48) 41.87 13.323 19-72
Total   60 (100) 112 (100) 40.65 12.910 19-72
Normal Male 10 (50) 18 (47) 39.15 14.412 19-66
Female 10 (50) 20 (53) 39.31 11.078 19-62
Total   20 (100)   38 (100) 39.24 12.685 19-66
Glaucoma suspect Male  11 (55) 20 (52)        39.1 13.822 19-67
Female   9 (45) 18 (48) 44.94 13.493 19-64
Total   20 (100)   38 (100) 41.87 13.808 19-67
Glaucoma Male 10 (50) 19 (52) 40.31       11.24 20-62
Female 10 (50) 17 (48) 41.47       10.65 21-63
Total   20 (100)   36 (100) 40.86       12.91 20-63
Age distribution of all subjects in the three study groups. There was no significant statistical difference in age among groups that could 
have affected the data (p = 0.964 for the normal group, 0.964 for the glaucoma suspect group, and 0.810 for the glaucoma group). This 
indicates that age did not have a significant on the data.
*One way ANOVA test. Significant when p < 0.05.
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Glaucoma suspect group
Twenty glaucoma suspect patients (38 eyes) were tested. 
The majority of patients (9 / 20) were diagnosed as glauco-
ma suspect based on high intraocular pressure recorded on 
multiple occasions, 5 / 20 had suspicious visual field re-
sults, and 3 / 20 had suspicious optic disc appearance with-
out established damage. Six sectors and five hemi-rings on 
each hemifield were compared to their corresponding fel-
lows on the opposite hemifield. Table 3 shows that 4 / 6 
sectors were found to have a statistically significant SNR 
difference when compared to their corresponding fellows, 
while 1 / 5 hemi-rings were statistically significant.
Glaucoma group
Twenty glaucoma patients (36 eyes) were tested. The 
majority of patients (14 / 20) had simple open angle glau-
coma (OAG), 3 / 20 had narrow angle glaucoma (NAG), 
and 1 / 20 had pseudoexfoliation glaucoma. There was 
considerable variation in the severity of glaucomatous field 
changes among tested patients. Variability ranged between 
mild to severe glaucomatous field losses using the Hod-
dap-Anderson criteria described earlier in the methods 
section. Most of the patients (13 / 20) had asymmetrical 
glaucomatous field changes between the two eyes, the rest 
(7 / 20) had symmetrical mild to moderate field changes. 
The HFA test showed only 3 / 36 eyes with advanced glau-
comatous changes with symmetrical severe field loss across 
the horizontal midline in both hemifields, all the rest (33 / 
36) showed clear differences between the two correspond-
ing hemifields. Six sectors and five hemi-rings on each 
hemifield were compared to their corresponding fellows on 
the opposite hemifield. Table 4 shows that all sectors and 
hemi-rings were statistically significant when compared to 
their corresponding fellows on the opposite hemifield. The 
results showed that the majority of patients had asymmet-
rical glaucomatous visual field defects between the two 
eyes; thus, confirming the importance of the monocular 
mfVEP test analysis. The mean SNR value for the glauco-
ma group was 1.70 ± 0.412, which is a low average response 
close to poor (SNR = 1).
3) Intergroup analysis
Signal to noise ratio analysis
The SNR values of all sectors and hemi-rings were com-
pared to their corresponding ones in the three study groups 
and showed statistical significance. Table 5 shows that the 
normal group represented the highest mean (2.85 ± 0.50) 
indicating better responses and signal strength, while the 
glaucoma group showed the lowest mean (1.71 ± 0.41) indi-
cating poor responses and signals. The glaucoma suspect 
group had a mid-range mean (2.27 ± 0.27) and lower vari-
ability. Table 6 shows the SNR values of each individual 
sector and hemi-ring compared to their corresponding 
ones in the three groups. The glaucoma suspect sectors and 
hemi-rings also showed a significant difference when com-
pared to the normal group. Fig. 6 shows the box plot repre-
sentation of the three groups.
Analysis of intergroup signal to noise ratio differences
SNR differences between each pair of corresponding sec-
tor and hemi-ring in each group were calculated and com-
pared to their corresponding values in the other study 
groups to identify any statistical significance. Fig. 7 shows 
a box plot representation of the mean SNR differences in 
the three groups. The range of SNR differences in the 
glaucoma group was higher and the mean was significant-
ly higher than the normal group. Table 7 shows that the 
glaucoma group had the largest SNR difference (mean, 
0.36 ± 0.321) compared to the normal group (mean, 0.28 ± 
0.22) and glaucoma suspect group (mean, 0.22 ± 0.18). Ta-
ble 8 shows the SNR differences calculated for each pair 
of corresponding sector and hemi-ring in each group. SNR 
differences for 11 pairs of sectors and hemi-rings were 
compared within the three groups to identify any statisti-
cally significant difference among the groups. The SNR 
difference was statistically significant in four sectors and 
three hemi-rings. The rest of the tested sectors and hemi-
rings were not statistically significant.
Humphrey visual field results
1) Reliability of the tests
Most of the reported tests were counted as reliable (103 
/ 112) after looking at the reliability index values and the 
GHT results. The rest of the tested eyes (9 / 112) showed 
various forms of poor reliability on the two separate tests. 
Fixation losses were the most common cause of poor reli-
ability (5 / 9) followed by false negatives (3 / 9). False posi-
tives were the least common (1 / 9). The majority of normal 
subjects showed reliable VF tests (36 / 38) followed by 
glaucoma patients (32 / 36) and glaucoma suspect patients 
(35 / 38). Among subjects in the unreliable field group, 
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glaucoma patients represented the majority (4 / 9) while 
normal subjects were the least unreliable among all study 
groups (2 / 9).
2) Global indices 
Two global indices were recorded and utilized in the 
HFA grading system; PSD and MD. Table 9 shows the dis-
tribution of these parameters among all study groups. 
There were evidently higher values in the glaucoma and 
glaucoma suspect groups compared to the normal group.
3)  Agreement between the Humphrey field analyzer and 
signal to noise ratio results
There was 88.9% agreement between the two tests in 
Table 2. Comparison between signal to noise ratio values in superior and inferior hemifield sectors and rings in the normal group
Variables
Superior hemifield Inferior hemifield
p-value*
N M SD N M SD
Pair 1 (SS1-IS1) 38 2.92 0.44 38 3.01 0.55 0.136
Pair 2 (SS2-IS2) 38 2.78 0.46 38 2.83 0.54 0.364
Pair 3 (SS3-IS3) 38 2.86 0.52 38 2.80 0.54 0.228
Pair 4 (SS4-IS4) 38 2.77 0.48 38 2.85 0.47 0.106
Pair 5 (SS5-IS5) 38 2.89 0.53 38 2.75 0.52 0.028 
Pair 6 (SS6-IS6) 38 2.84 0.55 38 2.93 0.49 0.298
Pair 7 (SR1-IR1) 38 2.84 0.46 38 2.88 0.50 0.321
Pair 8 (SR2-IR2) 38 2.82 0.53 38 2.86 0.53 0.478
Pair 9 (SR3-IR3) 38 2.95 0.55 38 2.87 0.46 0.148
Pair 10 (SR4-IR4) 38 2.81 0.41 38 2.87 0.56 0.320
Pair 11 (SR5-IR5) 38 2.85 0.45 38 2.76 0.45 0.091
Only one pair of sectors (SS5–IS5) showed a statistically significant difference in signal to noise ratio values. All other tested sectors 
and hemi-rings were not statistically significant.
N = number of eyes; M = mean difference in signal to noise ratio values; SD = standard deviation; SS = superior sector; IS = inferior 
sector; SR = superior hemi-ring; IR = inferior hemi-ring.
*Paired t-test, significant when p < 0.05.
Table 3. Comparison between signal to noise ratio values in superior and inferior hemifield sectors and rings in the glaucoma suspect group
Variables
Superior hemifield Inferior hemifield
p-value*
N M SD N M SD
Pair 1 (SS1-IS1) 38 2.03 0.43 38 2.18 0.51   0.232
Pair 2 (SS2-IS2) 38 1.85 0.35 38 2.20 0.47   0.001 
Pair 3 (SS3-IS3) 38 1.74 0.25 38 2.28 0.59 <0.001 
Pair 4 (SS4-IS4) 38 1.65 0.27 38 2.28 0.63 <0.001 
Pair 5 (SS5-IS5) 38 1.84 0.38 38 2.14 0.46   0.003
Pair 6 (SS6-IS6) 38 1.98 0.50 38 2.15 0.49 0.69
Pair 7 (SR1-IR1) 38 2.17 0.21 38 2.29 0.29   0.010 
Pair 8 (SR2-IR2) 38 2.24 0.29 38 2.22 0.21   0.556
Pair 9 (SR3-IR3) 38 2.24 0.23 38 2.29 0.29   0.225
Pair 10 (SR4-IR4) 38 2.33 0.23 38 2.33 0.30   0.930
Pair 11 (SR5-IR5) 38 2.34 0.31 38 2.31 0.29   0.508
Four pairs of sectors (4 / 6) showed a statistically significant difference in signal to noise ratio values, while only one hemi-ring (1 / 5) 
showed a statistically significant difference. All other tested sectors and hemi-rings were not statistically significant.
N = number of eyes; M = mean difference in signal to noise ratio values; SD = standard deviation; SS = superior sector; IS = inferior 
sector; SR = superior hemi-ring; IR = inferior hemi-ring.
*Paired t-test, significant when p < 0.05.
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Fig. 6. Box plot of signal to noise ratio (SNR) values of multi-
focal visual evoked potential in normal, glaucoma suspect, and 
glaucoma groups. There was a significant difference between the 
mean values among the three study groups.
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Fig. 7. Box plot of the difference in signal to noise ratio (SNR) 
values of multifocal visual evoked potential in normal, glaucoma 
suspect, and glaucoma groups. There was a significant difference 
between the mean values among the three study groups.
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Table 4. Comparison between signal to noise ratio values in superior and inferior hemifield sectors and rings in the glaucoma group
Variables
Superior hemifield Inferior hemifield
p-value*
N M SD N M SD
Pair 1 (SS1-IS1) 36 1.54 0.22 36 1.74 0.37   0.001 
Pair 2 (SS2-IS2) 36 1.58 0.21 36 1.83 0.49   0.002 
Pair 3 (SS3-IS3) 36 1.46 0.31 36 1.82 0.45 <0.001 
Pair 4 (SS4-IS4) 36 1.44 0.24 36 1.81 0.48 <0.001 
Pair 5 (SS5-IS5) 36 1.58 0.28 36 1.88 0.43 <0.001 
Pair 6 (SS6-IS6) 36 1.70 0.35 36 1.85 0.47   0.033 
Pair 7 (SR1-IR1) 36 1.50 0.20 36 1.74 0.33 <0.001 
Pair 8 (SR2-IR2) 36 1.52 0.26 36 1.70 0.41   0.002 
Pair 9 (SR3-IR3) 36 1.54 0.26 36 1.90 0.49 <0.001 
Pair 10 (SR4-IR4) 36 1.61 0.34 36 1.90 0.36   0.001 
Pair 11 (SR5-IR5) 36 1.77 0.53 36 2.02 0.55   0.001 
All pairs of sectors (6 / 6) and hemi-rings (5 / 5) showed a statistically significant signal to noise ratio difference.
N = number of eyes; M = mean difference in signal to noise ratio values; SD = standard deviation; SS = superior sector; IS = inferior 
sector; SR = superior hemi-ring; IR = inferior hemi-ring.
*Paired t-test, significant when p < 0.05.
Table 5. Comparison of total signal to noise ratio values in all sectors between study groups
Groups N M SD
95% Confidence interval for mean
p-value* 
Lower bound Upper bound
Normal 836 2.85 0.503 2.82 2.89 <0.001
Glaucoma suspect 836 2.27 0.276 2.25 2.29
Glaucoma 792 1.70 0.412 1.67 1.73
Total 2464 2.28 0.621 2.26 2.31
N = number of eyes; M = mean difference in signal to noise ratio values; SD = standard deviation.
*One way ANOVA test, significant when p < 0.05.
59
MF Mousa, et al. Hemifield Sector Analysis for Detection of Glaucoma
identifying normal subjects and 77.8% agreement in iden-
tifying glaucoma subjects.
Visual field grading system
1) Humphrey field analyzer grading analysis
Table 10 shows the distribution of visual field test grades 
in all study groups. The chi-square test was used to identi-
fy statistically sign cant differences in the number of tests 
that were recorded in each grade between groups. We 
found highly significant variation in the number of tests 
recorded in each group, indicating good validity of the 
grading system used. Grade 1 which means a normal visu-
al field test with no abnormalities was recorded for 39 sub-
Table 7. Comparison of the total difference in all sectors between study groups
Groups N M SD
95% Confidence interval for mean
p-value* 
Lower bound Upper bound
Normal 418 0.28 0.22 0.26 0.30 <0.001
Glaucoma suspect 418 0.22 0.18 0.20 0.24
Glaucoma 396 0.36 0.32 0.33 0.39
Total 1232 0.29 0.25 0.27 0.30
N = number of eyes; M = mean difference in signal to noise ratio values; SD = standard deviation.
*One way ANOVA test. Significant if p < 0.05.
Table 6. Comparison between groups of hemifield intersector signal to noise ratio values
Variables
Normal group Glaucoma suspect Glaucoma
p-value*
N M SD N M SD N M SD
SS1 38 2.93 0.44 38 2.32 0.24 36 1.54 0.22 <0.001 
IS1 38 3.01 0.55 38 2.34 0.25 36 1.74 0.37 <0.001 
SS2 38 2.78 0.46 38 2.21 0.29 36 1.58 0.21 <0.001 
IS2 38 2.83 0.54 38 2.25 0.26 36 1.83 0.49 <0.001 
SS3 38 2.86 0.52 38 2.17 0.28 36 1.46 0.31 <0.001 
IS3 38 2.80 0.54 38 2.34 0.30 36 1.82 0.45 <0.001 
SS4 38 2.77 0.48 38 2.23 0.26 36 1.44 0.24 <0.001 
IS4 38 2.85 0.47 38 2.24 0.29 36 1.81 0.48 <0.001 
SS5 38 2.89 0.53 38 2.21 0.26 36 1.58 0.28 <0.001 
IS5 38 2.75 0.52 38 2.28 0.34 36 1.88 0.43 <0.001 
SS6 38 2.84 0.55 38 2.28 0.25 36 1.70 0.35 <0.001 
IS6 38 2.93 0.49 38 2.25 0.23 36 1.85 0.47 <0.001 
SR1 38 2.84 0.46 38 2.17 0.21 36 1.50 0.20 <0.001 
IR1 38 2.88 0.50 38 2.29 0.29 36 1.74 0.33 <0.001 
SR2 38 2.82 0.53 38 2.24 0.29 36 1.52 0.26 <0.001 
IR2 38 2.86 0.53 38 2.22 0.21 36 1.70 0.41 <0.001 
SR3 38 2.95 0.55 38 2.24 0.23 36 1.54 0.26 <0.001 
IR3 38 2.87 0.46 38 2.29 0.29 36 1.90 0.49 <0.001 
SR4 38 2.81 0.41 38 2.33 0.23 36 1.61 0.34 <0.001 
IR4 38 2.87 0.56 38 2.33 0.30 36 1.90 0.36 <0.001 
SR5 38 2.85 0.45 38 2.34 0.31 36 1.77 0.53 <0.001 
IR5 38 2.76 0.45 38 2.31 0.29 36 2.02 0.55 <0.001 
Comparison of signal to noise ratio values in each sector and hemi-ring between the three groups. There was a highly significant 
statistical difference (p < 0.001) between groups in all tested sectors and hemi-rings.
N = number of eyes; M = mean difference in signal to noise ratio values; SD = standard deviation; SS = superior sector; IS = inferior 
sector; SR = superior hemi-ring; IR = inferior hemi-ring.
*One way ANOVA test, significant when p < 0.05.
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jects. Among them, 24 were from the normal group, 14 
from the glaucoma suspect group, and only one from the 
glaucoma group. Conversely, grade 5 which indicates se-
vere glaucomatous field loss was not recorded for any of 
the normal subjects (0 / 16), while the majority were from 
the glaucoma group (12 / 16) and the rest were from the 
glaucoma suspect group (4 / 16).
2) Signal to noise ratio grading analysis
Table 11 shows five different ranges of SNR values. Grade 
1 stands for a healthy normal response where the signal is 
≥3 times the average noise from the entire 58 field segments. 
Conversely, grade 5 stands for a low SNR value where the 
signal is almost equal or slightly more than the average 
noise, which is a value we expect to be found in a damaged 
sector or focal field defect. All SNR values <1 were consid-
ered as pure noise and were not counted in the analysis.
However, on the segment level, there were few <1 re-
cordings mostly in patients with advanced glaucoma. On 
the sector/hemi-ring level, there was no <1 value calculated 
because we excluded these values in the average of each 
sector and hemi-ring. Interestingly, Table 11 shows that 
grade 1 included 15 eyes; all of them were in the normal 
group, which gives good credibility to the classification 
system. Similarly, grade 5, which stands for a poor re-
sponse, included 7 eyes; all of them were glaucoma pa-
tients; thus, further confirming the credibility of this sim-
ple classification system. In addition, a highly significant 
distribution of these grades among the three groups was 
demonstrated by the chi-square test.
Discussion
We have shown that the Intersector analysis protocol 
was able to detect visual field defects in both glaucoma and 
glaucoma suspect groups. In addition, it was able to identi-
fy normal subjects as normal responses and accurately dif-
ferentiated normal responses from glaucomatous visual 
fields. With such promising results this protocol can be 
used to monitor glaucomatous changes in subjects with es-
tablished visual field defects and suspect patients who need 
close monitoring. Recent evidence suggests that mfVEP 
can be used to monitor and detect progression of glaucoma 
through good repeatability figures [6-8]. mfVEP has been 
used in clinical research on patients with various types of 
glaucoma to objectively evaluate functional loss in glauco-
ma. The results confirmed the ability and credibility of the 
mfVEP test to detect glaucomatous visual field loss. Gold-
berg et al. [17] used the mfVEP test to detect glaucomatous 
visual field defects already documented in glaucoma pa-
tients. Goldberg et al. found good correlation with HFA 
field results in glaucoma patients and reported that mfVEP 
can assess the visual field and identifies glaucomatous vi-
sual field defects. In addition, it may have the potential for 
identifying defects earlier than conventional perimetry.
There are many examples where HFA and mfVEP are 
not consistent and do not agree in the detection of visual 
field defects. In this study, the mfVEP analysis protocol 
detected glaucomatous field defects in both glaucoma and 
glaucoma suspect patients with a good level of sensitivity 
and specificity. Sensitivity and specificity of the HSA pro-
tocol in detecting glaucoma was 97% and 86%, respective-
ly, and for glaucoma suspect patients the values were 89% 
and 79%, respectively. These sensitivity values were simi-
lar to other research work done on mfVEP perimetry us-
ing different analysis protocols. The majority of studies 
identifying the role of mfVEP in detection of glaucoma-
tous visual field defects confirm its ability to detect already 
existed damages with high sensitivities ranging between 
86% and 97.5%. In addition, mfVEP was shown to identify 
defects not detected by SAP with lower sensitivities (76% 
to 92%), which is a very good detection rate compared to 
SAP results and its limitations in the early stages of glau-
coma [7,8].  Graham et al. [6] also reported similar results 
and showed evidence that mf VEP is an effective method 
for detecting visual field loss in glaucoma. They suggested 
that the mfVEP test provides a valuable aid to the clinician 
in categorizing patients with unreliable, variable, uncon-
firmed, or excessive subjective field loss.
For decades the HFA offered the gold standard visual field 
test using the full threshold strategy. Although it showed 
many shortcomings listed earlier, the HFA remained the 
best available method for detection and monitoring of 
glaucomatous visual field losses. The introduction of SITA 
with its novel method for algorithm calculation rectified 
some of the problems raised by the lengthy full threshold 
test and offered a new level of better reliability. After its 
introduction to the Humphrey analyzer and its integration 
into the standard software package, SITA became more 
popular and the majority of clinicians prefer to utilize it in 
their daily practice. In reality, SITA is not a true full thresh-
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old strategy; it is a computer generated program that was 
developed for the field analyzer II (Humphrey systems) 
that reduced test-taking time. Through its progress and de-
velopment, SITA Standard has been shown to reduce test 
duration by approximately 50% while SITA Fast reduces it 
by 70% [10]. However, many studies have compared the 
severity of glaucomatous visual field losses using more 
than a single test strategy; mainly SITA standard and full 
threshold algorithms [11,12]. Budenz et al. [13] evaluated 
visual field defects in patients with glaucoma using SITA 
Table 8. Comparison of hemifield intersector signal to noise ratio differences between groups
Variables
Normal group Glaucoma Suspect Glaucoma
p-value*
N M SD N M SD N M SD
SS1-IS1 38 0.27 0.20 38 0.22 0.19 36 0.29 0.24 0.289
SS2-IS2 38 0.30 0.19 38 0.25 0.27 36 0.36 0.38 0.265
SS3-IS3 38 0.27 0.18 38 0.28 0.23 36 0.48 0.48 0.004 
SS4-IS4 38 0.23 0.19 38 0.25 0.17 36 0.42 0.37 0.005 
SS5-IS5 38 0.33 0.20 38 0.24 0.18 36 0.38 0.28 0.045 
SS6-IS6 38 0.38 0.31 38 0.18 0.16 36 0.32 0.28 0.004 
SR1-IR1 38 0.21 0.12 38 0.24 0.15 36 0.28 0.17 0.355
SR2-IR2 38 0.25 0.18 38 0.20 0.16 36 0.29 0.23 0.156
SR3-IR3 38 0.26 0.26 38 0.22 0.16 36 0.44 0.35 0.002 
SR4-IR4 38 0.28 0.27 38 0.21 0.14 36 0.36 0.28 0.008 
S45-IR5 38 0.25 0.21 38 0.17 0.12 36 0.35 0.30 0.003 
Significant differences between groups in the Intersector comparison (superior and inferior). Most of the tested sectors were significant (7 / 11). 
N = number of eyes; M = mean difference in signal to noise ratio values; SD = standard deviation; SS = superior sector; IS = inferior 
sector; SR = superior hemi-ring; IR = inferior hemi-ring.
*One way ANOVA test, significant when p < 0.05.
Table 9. Swedish Interactive Threshold Algorithms standard global indices of the three study groups
Index
Normal Glaucoma suspect Glaucoma
M SD M SD M SD
Mean deviation 1.08 1.87 -2.51 4.25 -7.16 8.15
Pattern standard deviation 1.73 0.57  2.64 2.48  4.57 3.09
Values of mean deviation (M) and pattern standard deviation (SD) of the three groups. Higher values in the glaucoma and glaucoma 
suspect groups compared to the normal group were observed.
Table 10. HFA grades among groups
HFA grade
Group
Total p-value*
Normal Glaucoma suspect Glaucoma
1 24 14  1 39
2  8 14  2 24
3  6  3  7 16
4  0  3 14 17
5  0  4 12 16
   Total 38 38 36              112
HFA = Humphrey field analyzer.
*Chi-square test. Significant when p < 0.05.
<0.001
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standard and full threshold algorithms to determine 
whether results from these procedures can be compared 
when monitoring a glaucoma patient. They suggested that 
care should be taken when using threshold values to com-
pare glaucomatous defects in a patient when converting 
from full threshold to SITA algorithms. Similar results 
were also reported [11,12] highlighting the difference in 
threshold values between the two tests. However, other stud-
ies such as Sharma et al. [10] reported no significant differ-
ence between the two algorithms in their threshold values.
A new VEP method based upon multifocal technology 
[14], circumvents the problem. With the mfVEP technique, 
many (typically 58 to 60) spatially local VEP responses 
can be recorded simultaneously allowing spatially local-
ized damage to be identified. The limitation of convention-
al VEP in the assessment of individual locations in the reti-
na raised the idea of using the same principle of objectivity 
in obtaining information from multiple locations simulta-
neously rather than summed overall responses. The princi-
ple is to stimulate the retina on an isolated rather than cu-
mulative basis, and to process these signals individually in 
order to draw a map of different retinal sensitivities in var-
ious locations. Successful recordings should detect in this 
case any small scotomas or subtle depressions that reflect 
early functional loss. mfVEP provides a great extension of 
this model of multiple simultaneous stimulation of the en-
tire field of vision, presenting its results as a topographic 
map of the field of vision. mfVEP is a relatively new tech-
nique that has yet to find its place as an objective tool ac-
cepted in clinical practice. Hood and Greenstein [9] record-
ed mf VEPs from about 500 patients. Their f indings 
highlight the potential clinical uses of mfVEP as an objec-
tive tool in the assessment of glaucomatous visual field de-
fects. These include unreliable HFA tests, questionable or 
inconsistent HFAs, confirmation of HFA results, and de-
tection of early damage and progression. Recent evidence 
suggests that mfVEP can be used to monitor and detect 
progression of glaucoma through good repeatability fig-
ures [6-8]. The important issue of detecting glaucoma at 
early stages has yet to be thoroughly explored; however, 
the general answer seems clear. In some patients, mfVEP 
will surpass HFA in detection of early damage. In other 
patients, the reverse will be true. There are many examples 
where HFA and mf VEP are not consistent and do not 
agree in the detection of visual field defects. Previous stud-
ies [9,15] have shown that damage detected by mfVEP is 
missed by HFA. Furthermore, abnormal mf VEPs have 
been reported in patients with normal HFAs.
However, the use of latency in mfVEP as a measurable 
parameter in the diagnosis and monitoring of glaucoma-
tous visual field defects has been a source of controversy 
among researchers. Some studies, such as Brigell et al. [26], 
reported almost 100% sensitivity and specificity of mfVEP 
latency in detecting glaucomatous visual field defects. 
However, other studies [3,27] reported very small latency 
differences in fields with glaucomatous defects, indicating 
that latency is not a useful parameter in mfVEP assessment 
of the glaucomatous visual field. According to many previ-
ous studies, mfVEP signal amplitude shows a significant re-
duction or loss in glaucomatous visual fields [3,9,14,16]. On 
the other hand, latency seems to be less sensitive. This 
could be explained by the mechanism of cell death in glau-
coma, where demyelination of the optic nerve is not a fea-
ture or expected change in the course of glaucoma. This is 
in contrast to optic neuritis where marked latency delays 
are the main pathological change. Klistorner et al. [28] re-
Table 11. SNR grades among groups
Grade (average SNR range)
Group
Total p-value*
Normal Glaucom suspect Glaucoma
G1 (≥3) 15  0  0  15
G2 (2.5-2.99) 17  4  0  21 
G3 (2-2.49)  4 32  5  41
G4 (1.5-1.99)  2  2 24  28
G5 (1-1.49)  0  0  7   7
Total 38 38 36 112
SNR = signal to noise ratio.
*Chi-square test. Significant when p < 0.05.
<0.001
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ported similar results and showed evidence that mfVEP 
can be useful in detecting visual field defects due to central 
visual pathway lesions. In their study, they performed 
mfVEP tests on patients with various patterns of visual 
field loss due to central visual pathway lesions, including 
patients with known cortical lesions. They reported that 
mfVEP can detect field loss from cortical lesions but not 
in some cases of homonymous quadrantanopia, where the 
lesion may have been in the extra-striate cortex. Another 
study by Greenstein et al. [29] compared the results of 
standard HFA perimetry and mfVEP in detecting visual 
field defects in patients with strabismic amblyopia. They 
reported that both techniques are able to reveal deficits in 
visual function across the visual field of patients with stra-
bismic amblyopia. They also found that mfVEP is able to 
detect field defects in fellow eyes that are not detected by 
HFA. According to the definition of glaucoma, the disease is 
characterized by progressive loss of retinal ganglion cells pro-
ducing very specific and characteristic optic nerve head dam-
age and visual field defects. The shape and morphology of the 
optic disc is another variable factor that introduces additional 
difficulty to the initial assessment of glaucoma changes. 
Rapid progression in the modification and adjustment of 
mfVEP testing protocols has led to high expectations, es-
pecially with regards to early detection of glaucoma chang-
es, where the role of standard visual field testing proce-
dures is preceded by a significant level of ganglion cell 
damage. Because of its objectivity and reproducibility, 
which has been demonstrated in many studies [9,17,26-29], 
newer research work is aimed at investigating the use of 
mfVEP testing in early detection of glaucomatous visual 
field defects. mfVEP has demonstrated variability that 
arises from anatomical differences in the visual cortex, 
such as the location of the calcarine cortex V1 in relation 
to the placement of the external electrodes and differences 
in the local folding of the cortex within V1 [30]. Newer 
testing protocols and software have reduced this variability 
by comparing responses to similar corresponding points; 
either in the contralateral hemifield or the other eye [30,31]. 
One of the drawbacks of Interocular comparison (compar-
ing responses in similar locations between the eyes) is the 
possibility of bilateral glaucomatous damage. Thus, mon-
ocular mfVEP testing has been introduced and developed 
in many studies [9,15,17-19,28-31] resulting in the produc-
tion of more promising and less variable results, especially 
in comparison to the use of SNR values. It has been 
demonstrated that SAP is considered relatively insensitive 
to early glaucomatous changes, not just due to early ana-
tomical damage of ganglion cells but mainly due to the 
poor level of reliability [32].
Recent studies suggest that glaucoma suspects, who are 
at risk for developing significant glaucomatous damage in 
the future, could benefit from mfVEP studies, where SAP 
results do not show any significant pathological changes. 
Thienprasiddhi et al. [8] studied mfVEP responses from 
the eyes of patients with glaucoma suspect and those with 
ocular hypertension (OHT) to evaluate whether the tech-
nique could detect visual field defects in eyes with normal 
SAP results. They performed the mf VEP test on three 
groups; normal controls, glaucoma suspects, and ocular 
hypertensive patients. They found that mf VEP results 
were abnormal in 4% of the eyes from the normal control 
group, while abnormal mfVEP results were detected in al-
most 20% of the glaucoma suspect eyes and 16% of OHT 
eyes. They concluded that the new mfVEP technique us-
ing the monocular strategy with SNR comparison can de-
tect visual field defects in a minority of eyes with glauco-
matous optic discs and normal SAP results. Graham et al. 
[6] also evaluated the role of mfVEP in glaucoma practice. 
They reported that 92.2% of low risk suspects had normal 
mfVEP. They concluded that mfVEP is an effective meth-
od for detecting glaucomatous visual field defects.
Our protocol is different in that it overcomes the poor 
detection problems of binocular analysis and makes the 
standard reference sectors coming from within the same 
eye, which should offer more precession and accuracy. Ac-
cording to the pathophysiology of glaucoma, early defects 
usually start as localized isolated islands in one sector in 
one hemifield, then they gradually progress over time to 
form larger defects in one hemifield with similar early 
changes in the opposite hemifield. However, when the glau-
comatous visual field is advanced and both hemifields are 
equally damaged this analysis protocol will face the same 
problems and therefore will not be good in detecting sig-
nificant differences between the two hemifields. Interest-
ingly, even in patients with advanced glaucomatous de-
fects, where both hemifields are damaged, the hemifield 
analysis protocol probably equally confirmed the defect in-
directly by generalized low SNR values for both hemi-
fields. The advantage of this protocol is that it can detect a 
defect if a significant SNR difference between the two 
hemifields is recorded. In addition, it can prompt the clini-
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cian to downplay SNR values if advanced glaucomatous 
visual field defects are present. For this reason we modified 
the analysis protocol and added an SNR grading scale for 
monocular analysis, which be published soon. The ability 
of HSA to detect early and subtle visual field changes com-
pared to standard SAP testing protocols has shown good 
agreement with previous studies.
Other studies [7-10] have shown similar results and pro-
vided evidence that mfVEP can detect early glaucomatous 
visual field defects in glaucoma and glaucoma suspect pa-
tients. These results are in agreement with recent studies. 
As a theoretical framework for judging whether SAP or 
mfVEP can be more beneficial, Hood and Greenstein [9] 
provide a better understanding of the two tests based on 
comparison of matched probability plots between the two 
tests. They concluded that most of the time mfVEP can 
detect glaucomatous visual field defects earlier than SAP. 
However, the reverse can occur as well, assuming that SAP 
results are reliable. Their analysis suggested that the two 
tests will often agree. There are significant reasons which 
made the use of mfVEP as a primary tool for objective vi-
sual field testing limited. The test is lengthy, specifically in 
the two runs mode which is the one used for diagnosis and 
monitoring, the equipment is expensive compared to con-
ventional HFA and other machines, performing the test 
needs qualified and well-trained technical staff that can 
connect the electrodes accurately and monitor for any in-
tra-test errors. Despite this, many patients prefer the 
mfVEP test over standard HFA testing protocols because 
it is less dependent on patients’ responses. However, for 
clinicians it cannot be performed on all glaucoma patients 
in daily practice because of its lengthy testing duration. 
The interpretation of mfVEP test results is another limit-
ing factor, as it requires the clinician to possess a good 
knowledge of VEP testing and potential sources of testing 
error. All these factors have put the mfVEP test behind 
where it should be as a highly sensitive and repeatable ob-
jective perimetry testing tool.
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